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                                    INTRODUCTION
Nausea and Vomiting is one of the most distressing post operative complications, for the 
patients and health care providers. It  is rated equal to pain and drains hospital resources in 
terms of delayed discharges, increased medication, complications like wound dehiscence and 
aspiration pneumonitis.
There are certain risk factors that predispose the patient to an post operative nausea and 
vomiting. They include patient factors, anaethetic drugs, the surgery perse etc.
ENT surgery  is  one  of  the  surgical  factors  leading  to  higher  risk  of  post  operative 
vomiting, especially in adenotonsillectomics and mastoidectomy surgery.
Propofol is a  versatile intravenous anaesthetic agent which has clear advantages over 
other agents in terms of early recovery and its antiemetic effect. Whenever it is included in an 
anaesthetic  regime,  it  does  offer  protection  to  against  post  operative  nausea  and  vomiting 
through varying degrees.
In  our  hospital,  Mastoidectomy  for  the  age  upto  20  years  is  done  under  general 
anesthesia.
The usual General anaesthetic technique is of intravenous induction, opioid, Oxygen, 
nitrous oxide technique. But this technique which contains two major predisposing factors, i.e. 
opioids and nitrous oxide, along with other factors, and the surgical factors incapacitate the 
patient with nausea and vomiting in the post operative period.
 Middle ear surgeries are a special risk factor for post operative nausea and vomiting. 
During middle ear procedures, the stimulation of vestibular afferents, middle ear cavities, leads 
to post operative nausea and vomiting. during tympanoplasty procedures nitrous oxide fills the 
middle ear cavities. Administration of Nitrous oxide should be stopped atleast 15 mins prior to 
application of graft. Residual nitrous oxide not only disrupts the graft but also stimulation the 
vestibular nerves causing nausea and vomiting.
Many regimes and doses of propofol are studied which provide the best protection form 
post  operative  nausea  and  vomiting.  Apart  from  propofol  offering  protection  during 
maintenance  doses,  it  has  been  found  that  low  dose  subhypnotic  infusions,  and  small 
subhypnotic bolus offer protection from nausea and vomiting .This is cost effective.
The advantages of using propofol in ENT surgeries are low incidence of post operative 
nausea and vomiting , reduction in blood pressure with out increase in heart rate, preservation 
of middle  ear blood flow and excellent recovery profile   
AIM OF THE STUDY
To  evaluate  the  efficiency  of  combing  propofol  as  induction  agent  and  single 
subhypnotic dose of propofol at the end of surgery for prevention of post operative nausea and 
vomiting in modified radical mastoidectomy surgeries. 
PHARMACOLOGY OF PROPOFOL
History:
Work in the early 1970’s on substituted derivatives of phenol with hypnotic properties 
resulted in development of 2, 6, di isopropofol. The first clinical trial reported by Kay and 
Rolly in 1977, confirmed the potential of Propofol as an induction agent. With recognition of 
rapid clearance of Propofol, its use as an maintenance agent, sedation in Intensive care units 
and during regional anaesthesia came into use. 
Propofol is insoluble in water and was therefore initially prepared with Cremaphor EL. 
Because of the anaphylactoid reactions with cremaphor EL, this preparation was withdrawn 
from the market and propofol was reformulated as an emulsion. Propofol become commercially 
available in 1986. It is more expensive than thiopentone or methohexitol but it has become 
popular due to its favourable recovery characteristics and antiemetic effect.
Propofol in extremely useful where volatile anaesthetic cannot used and an intravenous 
technique must be employed as in rigid bronchoscopy, tracheobronchial surgery and in patients 
susceptible to malignant hyperthermia  
Chemical Structure:
(CH3)2 CH
Chemical Name: 2,6,-di isopropyl phenol
Physio Chemical Properties.
Propofol is one of a group of Alkyl phenols.
Alkyl phenols are oils at room temperature, insoluble in water, and highly lipid soluble 
Formulation:
a) Propofol 1%
Soya  bean oil 10%
Glycerol 2.25%
Purified egg phosphatide 1.2%
Preservatives: Disodium Edetate (0.005%) or Metabisulphite
b) Formulation with medium chain triglycerides and long chain triglycerides is available 
c) Clear  propofol is available , but has not gained popularity.
Availability  
10ml ampoules vials of 1% propofol
20ml vials of 1% propofol
20ml vials of 2% propofol
50ml vials of 1% propofol
50ml 1,2% Prefilled syringes for target controlled infusion techniques.
OH
CH (CH
3
)
2
All formulations are stable at room temperature and are not sensitive to light.
Change in diluent may result in slight changes in pharmacokinetics, cracking of emulsion and 
spontaneous degradation of propofol.
Propofol is compatible with 5% dextrose and can be used as dilutant .
Mechanism of Action
Propofol is presumed to exert its sedative-hypnotic effects through an interaction with 
Gamma-AminoButyric  acid (GABA),  the  principal  inhibitory  neurotransmitter  in  the  CNS, 
When  the  GABA  receptor  is  activated,  transmembrane  chloride  conductance  increases, 
resulting in hyperpolarization of the postsynaptic cell membrane and functional inhibition of 
the  postsynaptic  neuron.  The  interaction  of  Propofol  (also  barbiturates)  with  specific 
components of the GABA receptor complex appears to decrease the rate of dissociation of 
GABA from its receptor, thereby increasing the duration of the GABA-activated opening of the 
chloride channel with resulting hyperpolarization of cell membranes.
Pharmacokinetics 
Clearance of Propofol from the plasma exceeds hepatic blood flow, emphasizing that 
tissue uptake , possibly into the lungs, as well as metabolism, is important in removal of this 
drug from the plasma. Hepatic metabolism is rapid and extensive, resulting in inactive, water-
soluble Sulfate and Glucouronic acid metabolites that are excreted by the kidneys. Less than 
0.3% of a dose is excreted unchanged in urine. The elimination half-time is 0.5 to 1.5 hours, 
but more important, the context-sensitive half-time for propofol infusion lasting up to 8 hours is 
<40 minutes  (Hughes et al.1992). The context-sensitive half-time of propofol is minimally 
influenced by the duration of the infusion because of rapid metabolic clearance. When the 
infusion  is  discontinued  such  that  the  drug  that  returns  from  tissue  storage  sites  to  the 
circulation  is  not  available  to  retard  the  decrease  in  plasma  concentrations  of  the  drug. 
Propofol,  like  thiopental  and  alfentanil,  has  a  short  effect-site  equilibration  time  such that 
effects on the brain occur promptly after IV administration.
Despite the rapid clearance of Propofol by metabolism, there is no evidence of impaired 
elimination in patients with cirrhosis of the liver.  Renal dysfunction does not influence the 
clearance of Propofol despite the observation that nearly three-fourths of propofol metabolites 
are eliminated in urine  in the first  24 hours.  Patients  older  than 60 years  of age exhibit  a 
decreased  rate  of  plasma  clearance  of  propofol  compared  with  younger  adults.  The  rapid 
clearance of propofol confirms this drug can be administered as a continuous infusion without 
an excessive cumulative effect. Propofol readily crosses the placenta but is rapidly cleared from 
the  neonatal  circulation  (Dailland  et  al.,  1989).  The  effect  of  instituting  cardiopulmonary 
bypass on the plasma propofol concentration is unpredictable, with some studies reporting a 
decrease whereas other observations  fail to document any change .
Clinical Uses
1. Propofol  has  become  the  induction  drug  of  choice  for  many  forms  of  anesthesia, 
especially when rapid and complete awakening is considered essential. 
2. Continuous intravenous infusion of Propofol, with or without other anesthetic drugs, 
has become a commonly used method for producing IV “conscious” sedation or as part 
of a balanced or total IV anesthetic. 
3. Administration of propofol as a continuous infusion can be used for sedation of patients 
in Intensive care units, a 2% solution may be useful to decrease the volume of lipid 
emulsion administered with long-term sedation.
Induction of Anesthesia
The induction dose of Propofol in healthy adults is 1.5 to 2.5 mg/kg IV, with blood 
levels of 2 to 6 µg/ml producing unconsciousness depending on associated medications and the 
patient’s age. As with barbiturates, children require higher induction doses of Propofol on a 
milligram per kilogram basis, presumably reflecting a larger central distribution volume and 
higher clearance rate. Elderly patients require a lower induction dose (25% to 50% decrease) as 
a result  of a smaller central  distribution volume and decreased clearance rate (smith et  al., 
1994). Awakening typically occurs at plasma Propofol concentrations of 1.0 to 1.5 µg/ml. The 
complete  awakening  without  residual  CNS effects  that  is  characteristic  of  Propofol  is  the 
principal reason this drug has replaced thiopental for induction of anesthesia in many clinical 
situations. Although Propofol is more expensive than thiopental, the additional expense may be 
offset by decreased costs made possible by prompt awakening.
Intravenous Sedation
The  short  context-sensitive  half-time  of  Propofol,  even  with  prolonged  periods  of 
infusion, combined with the short effect-site equilibration time, make this an easily titratable 
drug for production of IV sedation. The prompt recovery without residual sedation and low 
incidence  of  nausea  and  vomiting  make  Propofol  particularly  well  suited  to  ambulatory 
conscious sedation techniques. The typical conscious sedation dose of 25 to 100 µg/kg/minute 
IV produces minimal amnestic effects (Smith et l., 1994). In selected patients, midazolam or an 
opioid  may  be  added to  Propofol  for  continuous  IV sedation.  A sense  of  well-being  may 
accompany recovery from conscious sedation with propofol, although this may be related more 
to the patient’s  relief that  the procedure is  over  than to  a specific  pharmacologic effect  of 
propofol. A conventional patient-controlled analgesia delivery system set to deliver 0.7-mg/kg 
doses of propofol with a 3-minute lockout period is an alternative to continuous infusion
Sedation techniques
Propofol has been administered as a sedative during mechanical ventilation in the ICU in 
a variety of patient population including postoperative patients (cardiac surgery, neurosurgery) 
and in patients with head injury . Propofol also provides control of stress responses and has 
anticonvulsant and amnestic  properties.  After cardiac surgery,  Propofol sedation appears to 
modulate postoperative hemodynamic responses by decreasing the incidence and severity of 
tachycardia and hypertension. Increasing metabolic acidosis, lipemic plasma, bradycardia, and 
progressive myocardial failure has been described in a few children who were sedated with 
Propofol during management of acute respiratory failure in the ICU (Parke et al., 1992).
Maintenance of Anesthesia 
The typical dose of Propofol for maintenance of anesthesia is 100 to 300 µg/kg/minute 
IV often in combination with a short-acting opioid (Smith et al., 1994). Although Propofol has 
proved  to  be  a  valuable  adjuvant  during  short  ambulatory  procedures,  its  use  for  more 
prolonged operations (>2 hours) is questionable based on the cost of the drug and only modest 
differences in recovery times compared with Propofol is generally associated with minimal 
postoperative  nausea and vomiting,  and awakening prompt,  with minimal  residual sedative 
effects.
Nonhypnotic Therapeutic Applications 
In addition to its clinical application as an IV induction drug, Propofol has been shown 
to have beneficial effects that were not anticipated when the drug was initially introduced.
Antiemetic Effects
The  incidence  of  postoperative  nausea  and  vomiting  is  decreased  when  Propofol  is 
administered, regardless of the anesthetic technique or anesthetic drug used. Subhypnotic doses 
of Propofol (10 to 20mg IV) may be used in the postanesthesia care unit to treat nausea and 
vomiting, particularly if it is not of vagal origin. In the postoperative period, the advantage of 
Propofol  is  it’  s  rapid onset  of  action and the  absence of  serious  side  effects.  Propofol  is 
efficacious in treating postoperative nausea and vomiting at plasma concentration that do not 
produce increased sedation. Studies indicate that antiemetic plasma concentrations of propofol 
are achieved by a single IV dose of 10 mg followed by 10  µg/kg/minute (Ganet al., 1997). 
Propofol in subhypnotic doses is effective against chemotherapy-induce nausea and vomiting. 
When administered to induce and maintain anesthesia, it is more effective than ondansetron in 
preventing postoperative nausea and vomiting (Gan et al., 1996).
Propofol has a profile of CNS depression that differs from other anesthetic drugs. In 
contrast to thiopental, for example, Propofol uniformly depresses CNS structures,  including 
subcortical centers. Most drugs of known antiemetic efficacy exert this effect via subcortical 
structures, and it is possible that Propofol modulates subcortical pathways to inhibit nausea and 
vomiting center. Nevertheless, the mechanisms mediating the antiemetic effects of Propofol 
remain unknown. An antiemetic system is unlikely in view of the observation that subhypnotic 
doses of Propofol fail to increase plasma prolactin concentration is characteristic of drugs that 
block the dopaminergic system. The antiemetic effect of Propofol is not due to the intralipid 
emulsion in the formulation (Gan et al., 1997).
Antipruritic Effects
Propofol,10 mg IV, is effective in the treatment of pruritus associated with neuraxial 
opioids or cholestasis. The quality of analgesia is not affected by Propofol. The mechanism of 
the antipruritic effect may be related to the drug’s ability to depress spinal cord activity. In this 
regard,  there  is  evidence  that  intrathecal  opioids  produce  pruritus  by  segmental  excitation 
within the spinal cord.
Anticonvulsant Activity 
Propofol  possesses  antiepileptic  properties,  presumably  reflecting  GABA-mediated 
presynaptic  and  postsynaptic  inhibition.  In  this  regard,  propofol  in  doses  of>1  mg/kg  IV 
decreases  seizure  duration  35%  to  45%  in  patients  undergoing  electroconvulsive  therapy 
(avramov  et  al.,  1995).  The  incidentce  of  excitatory  movements  and  associated 
electroencephalogram (EEG) changes are  low after the administration of Propofol.  Propofol 
does not produce seizure activity on the EEG when administered to patients with epilepsy, 
including those undergoing cortical resection 
EFFECTS ON ORGAN SYSTEM
Central Nervous System
Propofol decreases cerebral metabolic rate for oxygen (CMRO2), cerebral blood flow, 
and intracranial  pressure  (ICP).  Large  doses  of  propofol,  however,  may decrease  systemic 
blood  pressure  sufficiently  to  also  decrease  cerebral  perfusion  pressure.  Cerebrovascular 
autoregulation in response to change in systemic blood pressure and reactivity of the cerebral 
blood flow to changes in carbon dioxide partial pressure are not affected by Propofol. Indeed, 
cerebral  blood flow velocity  changes  in  parallel  with changes in PaCo2 in  the  presence of 
propofol and midazolam. Propofol produces cortical EEG changes that are similar to those of 
thiopental, including the ability of high doses to produce burst suppression. Propofol produces 
a decrease in the changes in the end-tidal Pco2 (PETCO2) produce corresponding changes in the 
cerebral  blood flow velocity   (CBFV) during infusion of propofol  or  midazolam. Cerebral 
vasomotor  responsiveness  to  carbon  dioxide  is  preserved  during  propofol  and  midazolam 
anesthesia in humans. Propofol does not interfere with the adequacy of electrocorticographic 
recording  during  awake  craniotomy performed  for  the  management  of  refractory  epilepsy, 
provided administration is discoutinued at least 15 minutes before recording (Herrick et al ., 
1997).  At  equal  sedation,  propofol  produces  the  same  degree  of  memory  impairment  as 
midazolam, whereas thiopental has mild memory effect and fentanyl has none .
Cardiovascular System
Propofol  produces  decreases  in  systemic  blood  pressure  that  are  greater  than  those 
evoked by comparable doses of thiopental  (Rouby et al ., 1991). These decreases in blood 
pressure  are  often  accompanied  by  corresponding  changes  in  cardiac  output  and  systemic 
vascular  resistance.  The  relaxation  of  vascular  smooth  muscle  produced  by  Propofol  is 
primarily due to inhibition of sympathetic vasoconstrictor nerve activity . A negative inotropic 
effect of Propofol may result from a decreases in intracellular calcium availability secondary to 
inhibition of trans-sarcolemmal calcium influx. Stimulation produced by direct laryngoscopy 
and intubation of the trachea reverses the blood pressure effects of Propofol, although this drug 
is more effective than thiopental in blunting the magnitude of this pressor response. Propofol 
also effectively blunts the hypertensive responses to placement of a laryngeal mask airway. 
Although able to blunt the increase in epinephrine concentration that accompanies a sudden 
increase in the delivered desflurane concentration, propofol, 2mg/kg IV, does not attenuate the 
transient  cardiovascular  response  to  a  rapid  increase  in  the  concentration  of  this  volatile 
anesthetic  to>1  MAC.   The  blood  pressure  effects  of  propofol  may  be  exaggerated  in 
hypovolemic patients, elderly patients, and patients with compromised left ventricular function 
due to coronary artery disease. Adequate hydration before rapid IV administration of Propofol 
is recommended to minimize the blood pressure effects of this drug. Addition of nitrous oxide 
does not alter the cardiovascular effects of Propofol.
Despite decreases in systemic blood pressure,  heart  rate often remains unchanged in 
contrast to the modest increases that typically accompany the rapid IV injection of thiopental. 
Bradycardia  and  asystole  have  been  observed  after  induction  of  anesthesia  with  Propofol, 
resulting in the occasional recommendation that anticholinergic drugs be administered when 
vagal stimulation is likely to occur in association with administration of Propofol. Propofol 
may decrease sympathetic  nervous system activity to a greater extent than parasympathetic 
nervous system activity, resulting in a predominance of parasympathetic activity (Bryson et al., 
1995).  There is also evidence that  Propofol does not alter sinoatrial  or atriventricular node 
function in normal patients or in patients with Wolff-Parkinson-White syndrome. Baroreceptor 
reflex control of heart rate may be depressed by propofol (Deutschman et al., 1994).
Bradycardia – Related Death
Profound bradycardia and asystole after administration of propofol have been described 
in healthy adult patients, despite prophylactic anticholinergics (Egan and Brock, 1991; Freysz 
et al., 1991; James et al., 1989; Tramer et al., 1997c). The risk of bradycardia-related death 
during propofol anesthesia has been estimated to be 1.4 in 100,000.  Severe, refractory, and 
fatal bradycardia in children in the ICU has been observed with long-term propofol sedation 
(Bray,  1995;  Dearlove  and  Dobson,  1995).  Propofol  anesthesia,  compared  with  other 
anesthetics, increase the incidence of the oculocardiac reflex in pediatric strabismus surgery, 
despite prior administration of anticholinergics (tramer et al., 1995c).
Lungs 
Propofol produces dose-dependent depression of ventilation,  with apnea occurring in 
25% to 35% of patients after induction of anesthesia with Propofol. Opioids administered with 
the preoperative medication may enhance this ventilatory effect. Painful surgical stimulation is 
likely to counteract the ventilatory depressant effects of propofol. A maintenance infusion of 
propofol decreases tidal volume and frequency of breathing. The ventilatory response to carbon 
dioxide and arterial hypoxemia are decreased by propofol (Blouin et al., 1993). Propofol can 
produce bronchodilation and decrease the incidence of intraoperative wheezing in patients with 
asthma. Propofol infusion to produce conscious sedation significantly decreases the slope and 
causes a downward shift of the ventilatory response to hypoxia (Blouin et al., 1993). Hypoxic 
pulmonary vasoconstriction seems to remain intact in patients receiving Propofol.
Hepatic and Renal Function 
Propofol  does  not  adversely  affect  hepatic  or  renal  function  as  reflected  by 
measurements of liver transaminase enzymes or creatinine concentrations. Prolonged infusions 
of Propofol may result in excretion of green urine, reflecting the presence of phenols in the 
urine. This discoloration does not alter renal function. Urinary uric acid excretion is increased 
after  administration  of  Propofol  and  may  manifest  as  cloudy  urine  when  the  uric  acid 
crystallizes in the urine under conditions of low pH and temperature (Masuda et al., 1997). This 
cloudy  urine  is  not  considered  to  be  detrimental  or  indication  of  adverse  renal  effects  of 
Propofol.
Intraocular Pressure
Propofol  is  associated  with  significant  decreases  in  intraocular  pressure  that  occur 
immediately after induction of anesthesia and are sustained during tracheal intubation .
SIDE EFFECTS 
Allergic Reactions
Allergenic  components  of  Propofol  include  the  phenyl  nucleus  and diisopropyl  side 
chain. Patients who develop evidence of anaphylaxis on first exposure to Propofol may have 
been previously sensitized to the diisopropyl radical, which is present in many dermatologic 
preparations. Likewise, the phenol nucleus is common to many drugs. Indeed, anaphylaxis to 
Propofol during the first exposure to this drug has been observed, especially in patients with a 
history of other drug allergies, often to neuromuscular-blocking drugs.
Proconvulsant Activity
The majority of reported Propofol-induced seizures during induction of anesthesia or 
emergence from anesthesia reflect spontaneous excitatory movements of sub-cortical origin. 
These  responses  are  not  thought  to  be  due  to  cortical  epileptic  activity,  although  some 
recommend  caution  in  administering  Propofol  to  patients  with  poorly  controlled  epilepsy. 
Prolonged  myoclonus  associated  with  meningismus  has  been  associated  with  Propofol 
administration (Hughes and Lyons, 1995).
Abuse Potential 
Intense dreaming activity,  amorous behaviour,  and hallucinations have been reported 
during recovery from the effects of Propofol. Addiction to virtually all opioids and hypnotics, 
including propofol, has been described (Follette and Farley, 1992).
Bacterial growth
Propofol strongly supports the growth of Escherichia coli and Pseudomonas aeruginosa, 
whereas the solvent appears to be bactericidal for these same organisms and bacteriostatic for 
Candida  albicans.  Clusters  of  postoperative  surgical  infections  manifesting  as  temperature 
elevations  have been attributed to extrinsic contamination of  Propofol  (Nichols  and Smith, 
1995). For this reason, it is recommended that (a) an aseptic technique be used in handling 
Propofol as reflected by disinfecting the ampoule’s neck surface or vial rubber stopper with 
70%  isopropyl  alcohol;  (b)  the  contents  of  the  ampoule  containing  Propofol  should  be 
withdrawn into a sterile syringe immediately after opening and administered promptly; and (c) 
and contents of an opened ampoules must be discarded if they are not used within 6 hours. In 
the ICU, the tubing and any unused portion of propofol must be discarded after 12 hours. 
Despite  these  concern,  there  is  evidence  that  when  Propofol  is  aseptically  drawn  into  an 
uncapped syringe, it will remain sterile at room temperature for several days 
Antioxidant Properties 
Propofol  has  potent  antioxidant  properties  that  resemble  those  of  the  endogenous 
antioxidant vitamin E . A neuroprotective effect of propofol may be at least partially related to 
the antioxidant potential of propofol’s phenol ring structure. For example, propofol reacts with 
lipid peroxyl radicals and thus inhibits lipid peroxidation by forming relatively stable propofol 
phenoyl radicals. In addition, propofol also scavenges peroxynitrite, which is one of the most 
potent  reactive  metabolites  for  the  initiation  of  lipid  peroxidation.  Because  peroxynitrite-
scavenging activity to suppress phagocytosis , propofol might be beneficial in disease states, 
such as acute lung injury, in which peroxynitrite formation is thought to play an important role 
(Kooy et al., 1995).
Pain on Injection 
Pain on injection is the most commonly reported adverse event associated with propofol 
administration to awake patients. This unpleasant side effect of propofol  occurs in <10% of 
patients when the drug is injected into a large vein rather than a dorsum vein on the hand. By 
prior administration of a potent short-acting opioid or 1% lidocaine decreases the incidence of 
discomfort experienced by the patient. The incidence of  thrombosis  or phlebitis is usually 
<1%. Changing the composition of the carrier fat emulsion for propofol to long- and medium 
chain trigelycerides decreases the incidence of pain on injection (Doenicke et al., 1997).
Accidental intra-arterial injection of propofol has been described as producing severe 
pain but no vascular compromise (Holley and Cuthrell, 1990). In an animal model, propofol-
exposed arteries showed no changes in the vascular smooth muscle, and the endothelium was 
not damaged (MacPherson et al., 1992).
Miscellaneous Effects
Propofol does not trigger malignant hyperthermia and has been administered to patients 
with  hereditary  coproporphyrias  without  ontoward  incidents.  Secretion  of  cortisol  is  not 
influenced by propofol, even when administered for prolonged periods in the ICU. Temporary 
abolition of tremors in patients with Parkinson’s disease may occur after the administration of 
propofol.  For  this  reason,  propofol  may  not  be  ideally  suited  for  patients  undergoing 
sertrotactic neurosurgery such as pallidotomy.
HISTORICAL ASPECTS : 
POSTOPERATIVE NAUSEA AND VOMITING
During ether era, reported incidence of post operative nausea and vomiting was as high 
as 75-80%. Various techniques including olive oil and glucose insulin injection were reported 
to be effective as reported by Robert Ferguson in 1912. The effect of atropine was appreciated 
by Brown Sequard as early as 1883.
In  second  half  of  the  century  the  incidence  of  post  operative  nausea  and  vomiting 
decreased  to  about  50%  due  to  the  use  of  non  opoid,  non-ether  regional  anaesthetics 
techniques,  refinement  of  surgical  techniques  and  identification  of  patient’s  predictive 
emetogenic  factors.  There  are  3  kinds  of  vomiting,  the  first  of  which  is  attributed  to 
anaesthetics such as ether, second due to the reflex responses, third due to the medication used 
intra operatively. Subsequent investigation unfolded a spectrum of non-anesthetic factors in the 
pathogenesis of post operative nausea and vomiting.
Over years  numerous of drugs have been used in the management of post  operative 
nausea  and vomiting.  Phenothiazines  were  synthesized  in  late  19th century  by  chemists  in 
dyeing  industry.  Promethazines  were  found  in  1930  to  have  good  anti  emetic  property. 
However sedative action of it, limited its use. Phenothiazine derivatives have been exclusively 
used in the treatment of post operative nausea and vomiting.
Antiemetics may be antagonists at the dopamine (D2-e.g. metoclopramide, droperidol, 
prochlorperazine),  5-HT3 (e.g.ondansetron,  dolasteron)  and  cholinergic  (e.g.  cyclizine) 
receptors. 
There  are  new  antiemetics  like  neurokinin  -1,  (substance  –  P  antagonists)  in 
development.
1. Complexity of the problem: The variables are many that it becomes difficult to assess 
the  effects  of  an intervention as  it  requires  considerable  number  of  patients  of  well 
controlled trails.
2. Inadequate quantification of phenomena: The phenomena has been poorly defined 
i.e. nausea, vomiting, retching etc.
3. Inadequate antiemetic regimen: Unable to identify a good drug which can prevent 
nausea and vomiting.
4. Animal  Model: A  lack  of  model  to  study  the  physiology  and  pharmacology  of 
mechanism  of  post  operative  nausea  and  vomiting,  though  monkey  and  dogs  are 
available they don’t suffer from pregnancy and motion sickness and post operative and 
post anesthetic emesis.
   POST OPERATIVE NAUSEA AND VOMITING
Morbidity  and  mortality  resulting  directly  from  anaesthesia  is  now  extremely  rare. 
However, postoperative nausea and vomiting (post operative nausea and vomiting) is still very 
common.  Surveys  have  confirmed  that  post  operative  nausea  and  vomiting  is  feared 
considerably by patients undergoing surgery. Indeed, it often comes before postoperative pain 
when patients are asked to rank their concerns. Therefore, every anaesthetist must be aware of 
the physiology of post operative nausea and vomiting and its consequences, causes, associated 
factors and management. 
VOMITING REFLEX 
All reflexes, including the vomiting reflex, consist or afferent inputs, a degree of central 
processing and motor efferents.  
VOMITING CENTRE
The vomiting centre is not an anatomical entity but represents several nuclei in the brain 
stem (e.g. nucleus tractus solitarius, respiratory neural networks) which are responsible for the 
coordination of the afferent limb of the vomiting reflex. It  receives input from the afferent 
limbs of the reflex and the chemoreceptor trigger zone (CTZ).
CHEMORECEPTOR TRIGGER ZONE 
 The CTZ is situated in the area postrema in the floor of the fourth ventricle. Evidence 
from ablation studies by Borison and Wang in the 1950s and the fact that the blood – brain 
barrier  is  defective  in  this  area  suggest  that  the  CTZ  is  responsible  for  detecting  toxins 
circulating in the blood and cerebrospinal fluid. However, it may be that a more precise area for 
this function is the nearby nucleus tractus solitarius where dopamine and opioid receptors are 
abundant. 
AFFERENT LIMBS OF VOMITING REFLEX 
Gastrointestinal tract 
Information from mechano-and chemoreceptors in the gastrointestinal tract is relayed 
via the vagus nerve to the nucleus tractus solitarius in the brain stem. Abnormal gastric or 
interstinal  distension,  increased  smooth  muscle  contraction  and  abnormal  or  toxic 
gastrointestinal  contents  can  trigger  the  vomiting  reflex.  Peripheral  5-HT3  receptors  are 
intimately involved in this system. Radiation, chemotherapy and other toxin release 5-HT from 
chromaffin cells in the gut, which stimulates vagal afferents – a process inhibited by the 5-HT3 
antagonist antimetics. Dopamine receptors are also abundant in the upper gastrointestinal tract. 
Vestibular system 
Input from the vestibular system is responsible for motion sickness, particularly when 
vestibular and visual signals conflict. Patients with a history of motion sickness and those who 
are moved excessively in the early postoperative period are more likely to suffer from post 
operative nausea and vomiting. 
Cardiovascular system 
Stimulation of  afferents  from both cardiac  ventricles  and blood vessels  may lead to 
vomiting.  For  example,  hypotension,  and  myocardial  infarction  are  often  associated  with 
nausea and vomiting. 
Higher centers 
Input from higher centers often plays a vital role in the genesis of post operative nausea 
and vomiting.  A calm,  well  informed patient  who is  denied unpleasant  sights,  sounds and 
smells is less likely to experience nausea or vomiting. 
Miscellaneous inputs 
Nausea and vomiting are frequently induced by stimulation of pharyngeal afferents, e.g. 
nasopharyngeal tube, endoscopy. Stimulation of the auricular branch of the vagus nerve on 
examination of the ear with an auroscope may induce sudden vomiting, especially in children. 
The role of sympathetic innervation of the gastrointestinal tract in post operative nausea 
and vomiting is not clear. However, pain pathways from the viscera reside in the splanchnic 
nerves and visceral pain is a frequent cause of nausea and vomiting. 
EFFERENT LIMB OF THE VOMITING REFLEX 
Nausea 
Nausea is not an inevitable consequence of vomiting but it is often the most troublesome 
symptom after surgery and anaesthesia. It is thought to be caused by the same stimuli that are 
responsible for vomiting, but the nature of the higher centers involved in this sensation are 
unknown. As a symptom, it is difficult to investigate because it is entirely objective and cannot 
be measured in animals. However, a consistent finding is that antiemetic therapy is often very 
effective in reducing the incidence of vomiting or retching, but less so for nausea. 
Vomiting 
In  the  prodromal  or  pre-ejection  phase,  there  is  a  relaxation  of  the  gastric  muscles 
followed by small intestinal retrograde peristalsis. The latter forces intestinal contents into the 
relaxed stomach. At the beginning of the ejection phase, the anterior abdominal muscles and 
the  diaphragm  contract  together,  accompanied  by  retrograde  contraction  of  the  striated 
musculature of the oesophagus. At the same time, the upper oesphageal sphincter becomes 
widely  dilated.  During  vomiting,  the  oesophagus  is  not  obstructed  by  diaphragmatic 
contraction,  as  the  crural  (peri-oesophageal)  muscles  of  the  diaphragm  are  relaxed.  This 
autonomic and somatic activity is coordinated in the brain stem. 
Retching  
Retching  (i.e.,  unproductive  vomiting)  often  occurs  before  vomiting  and  when  the 
retrograde intestinal peristasis reaches the stomach. During retching, the abdominal muscles 
and diaphragm contract less intensely and there is no retrograde oesophageal contraction or 
crural relaxation. Clinically, retching is a frequent and distressing symptom, often associated 
with intense nausea. 
ADVERSE EFFECTS OF POST OPERATIVE NAUSEA AND VOMITING  
 The most important and frequent adverse effect is the profound distress of most patients 
when they experience nausea and vomiting. 
Aspiration  of  stomach  contents  is  an  important  cause  of  anaesthetic  mortality  and 
morbidity  and  can  occur  in  the  postoperative  period,  particularly  if  the  patient  is  drowsy. 
Nausea and vomiting make this more likely. Post Operative Nausea and Vomiting may limit 
significantly  the  dose  of  opioid  that  may  be  given  for  pain  relief,  and  prevention  with 
antiemetics  enables  effective  doses  to  be  administered.  Oral  administration  of  drugs  (e.g. 
analgesics, antihypertensives), fluids and nutrients are delayed by post operative nausea and 
vomiting  and,  if  prolonged,  may  cause  significant  problems.  Post  operative  nausea  and 
vomiting is often more severe on movement and may delay postoperative mobilization. It is 
also  an  important  cause  of  delayed  discharge  from  day-care  surgery  units,  including 
unscheduled overnight stay. 
FACTORS  ASSOCIATED  WITH  POST  OPERATIVE  NAUSEA  AND 
VOMITING  
 Many  studies  have  investigated  the  relative  importance  of  patient,  surgical  and 
anaesthetic factors in the incidence of post operative nausea and vomiting. Some factors have 
been associated with an increased risk, but presently the likelihood of post operative nausea and 
vomiting in individual patients cannot be predicted with any certainty. 
Patient factors 
Studies have revealed several patient factors which are associated with a relatively high 
risk of post operative nausea and vomiting. A previous history of post operative nausea and 
vomiting  is  a  strong  association.  Children  and  females  are  at  greater  risk  but  there  is  no 
difference between the sexes in childhood or old age. The influence of the menstrual cycle and 
obesity has been investigated but there is no consistent evidence that they are an important 
factors. However, it is likely that a predisposition to travel sickness is important.
Surgical factors 
Major  and  minor  gynaecological  procedures  are  associated  consistently  with  post 
operative  nausea  and  vomiting.  Indeed,  gynaecological  surgery  is  often  used  in  studies 
investigating the efficacy of new antiemetics. Post operative nausea and vomiting after ENT 
surgery may be more frequent because of stimulation of pharyngeal afferents,  blood in the 
gastrointestinal  tract  and the fact  that  it  is  a  common procedure  in  children.  In abdominal 
surgery, almost all the efferent limbs of the vomiting reflex are stimulated. Duration of surgery 
and anaesthesia may also be important. 
Anaesthetic factors 
Choice of induction agent may influence the incidence of post operative nausea and 
vomiting. Etomidate and methohexital are comparatively more emetogenic. The incidence of 
post operative nausea and vomiting associated with induction and, maintenance, anaesthesia 
with propofol is lower than that with other intravenous and volatile agents. Indeed, it has been 
suggested  that  propofol  has  antiemetic  properties,  but  the  evidence  for  this  is  not  yet 
convincing. 
Nitrous oxide when used alone, e.g., Entonox, may cause nausea and vomiting, but its 
effect  is  uncertain when used as part  of  a balanced anaesthetic  technique.  Modern volatile 
agents  are  less  emetogenic  compared  with  older  agents,  e.g.  ether,  trichloroethylene, 
methoxyflurane,  but  still  contribute  to  the  overall  likelihood  of  post  operative  nausea  and 
vomiting. 
It  is  clear  that  the  perioperative  use  of  opioids  (oral,  i.m.,  i.v.  epidural,  spinal)  is 
associated  with  an  increased  incidence  of  post  operative  nausea  and  vomiting  and  many 
anaesthetic techniques aim to avoid opioids for the reason. Paradoxically, postoperative pain 
may cause post operative nausea and vomiting, which may be alleviated by judicious use of 
opioids. 
Antagonism of  neuromuscular  blockade  with  neostigmine  has  been  blamed for  post 
operative  nausea  and  vomiting  but  recent  data  have  not  confirmed  this.  Episodes  of 
hypotension during spinal or epidural anaesthesia are a common cause of nausea and vomiting. 
Indeed, nausea is often the first sign of this problem. In addition, there is a lower incidence of 
post  operative  nausea  and  vomiting  in  patients  anaesthetized  by  experienced  anaesthetics 
compared with those managed by novices. The inexperienced tend to maintain anaesthesia at a 
deeper plane and are more likely to inflate the stomach with air during manual ventilation. 
APFEL ET AL: PREDICTORS OF POST OPERATIVE NAUSEA AND VOMITING
Several  post  operative  nausea  and vomiting  risk  scores  are  available.  One  score  by 
Sinclair, Chung and Mezei considers 12 predictors (Sinclair-score) while another, by Apfel and 
colleagues, considers just four risk factors (Apfel-score). 
Apfel  predictors  significantly  indicate  the  probability  of  post  operative  nausea  and 
vomiting
Multivariable  analysis  revealed  that  age,  gender,  previous  history of  post  operative 
nausea and vomiting or motion sickness and postoperative use of opioids had an impact on post 
operative  nausea  and  vomiting.  Logistic regression  analysis  was  restricted  to  these  four, 
strongest factors.
1. Age inversely correlated with post operative nausea and vomiting which corresponded to a 
17%  decrease of  the  probability  of  post  operative  nausea  and  vomiting  for  a  ten-year 
increase in age. 
2. Male sex was also associated with a lower incidence of post operative nausea and vomiting 
3. A previous history of post operative nausea and vomiting or motion sickness and the
4. Postoperative use of opioids increased the risk of post operative nausea and vomiting more 
than fourfold. 
MANAGEMENT OF POST OPERATIVE NAUSEA AND VOMITING    
Prevention of post operative nausea and vomiting  
Prevention rather than treatment of post operative nausea and vomiting should be the 
anaesthetist’s aim. However, there is no agreed protocol as to which patients should receive 
preventive  antiemetic  therapy,  but  the  relative  indication  for  prophylaxis  increases  as  the 
number of risk factors increase. 
There is an important organization factor in the incidence of post operative nausea and 
vomiting.  Antiemetics  are  often  prescribed  but  not  given.  The  overall  incidence  of  post 
operative nausea and vomiting in a hospital is reduced if all professionals involved in the care 
of  the  patient  understand  the  importance  and  nature  of  antiemetic  therapy  and  an  agreed 
management protocol is in place. 
TREATMENT OF POST OPERATIVE NAUSEA AND VOMITING  
Treat the cause 
An important principle in the management of any symptom is to seek and treat the cause 
before  treating the  symptom itself.  This  is  relevant  when dealing with  a patient  with post 
operative nausea and vomiting.
Post  operative  nausea  and  vomiting  may  indicate  postoperative  hypotension;  simply 
administering  an  antiemetic  does  not  help  and  may  mask  an  important  sign.  Hypoxaemia 
should  be  treated  with  oxygen and investigated  further  if  necessary.  Early  fluid  intake  or 
mobilization, particularly after day-case surgery is a common cause. psychological factors, e.g. 
anxiety,  loss  of  control  and  illness  beliefs,  play  an  important  role  and  may  respond  to 
appropriate  non-pharmacological  management.  Occasionally,  post  operative  nausea  and 
vomiting may herald significant intra-abdominal or other pathology resulting from a surgical 
complication. This should be borne in mind constantly, particularly before discharge from the 
day-care unit. 
Opioids are a common cause of post operative nausea and vomiting, particularly if they 
are administered injudiciously. Changing to a local anaesthetic technique or adopting a more 
balanced approach to analgesia may solve the problem. It should be remembered that many 
other  drugs  are  emetogenic.  Antibiotics  are  a  common  culprit  and  their  use  should  be 
reassessed if post operative nausea and vomiting  is a severe problem. 
Antiemetic therapy 
 In practice, many patients with post operative nausea and vomiting require parenteral 
antiemetic therapy.  If  an antiemetic has been given previously,  there are several  factors  to 
consider when choosing the appropriate drug. If the previous drug was effective for some time 
and  it  is  likely  that  is  plasma  concentrations  are  now  low,  it  is  probably  appropriate  to 
administer the same drug. However, if the drug was administered relatively recently, a different 
antiemetic  is  required.  It  makes  pharmacological  sense  to  choose  a  drug  which  acts  at  a 
different receptor. 
Types of antiemetic 
Dexamethasone  and  cannabinoids  (e.g.,  nabilone,  dronabinol)  are  effective  against 
chemotherapy-induced emesis.  The  efficacy  of  cannabinoids  for  post  operative  nausea  and 
vomiting  is  uncertain  but  there  is  increasing  evidence  that  dexamethasone  is  effective. 
Antagonists at the NK-1 receptor are antiemetic also and their site of action is probably in the 
brain stem where  there is  an abundance of these  receptors.  They are presently  undergoing 
clinical trials. 
Non pharmacological methods : Acupuncture ,  Acupressure
   The effect of P6 acupressure point ahs been described but its effect on preventing post 
operative nausea vomiting is doubtful.   
ANTIEMETIC EFFECT OF PROPOFOL
Propofol possesses some interesting properties which is not shown by other anaesthetic 
agents. They are its antiemetic effect, its antipruritic effect, its antioxidant effect and a sense of 
well being after a Propofol anaesthetic. Of these characteristics, its antiemetic effect is the one 
much investigated and used property. Its antiemetic effects shows up in the post anaesthetic 
period as a large reduction in the incidence of post operative nausea and vomiting. Studies and 
researches done on antiemetic effect of propofol varies from dosage, routes of administration, 
effective plasma concentration required to prevent nausea and vomiting to receptor - cellular 
level where propofol exerts its antiemetic effect. 
Mechanism of action 
A biological basis for propofol being an antiemetic is lacking. 
1. Propofol does not interact with D2 Dopamine receptors, and propofol did not prevent 
vomiting induced by dopamine agonist apomorphine. 
2. Other  vague  mechanism includes  direct  depressant  effects  on  chemoreceptor  trigger 
zone, vagal nuclei and other centres implicated   in nausea and vomiting.
3. Propofols’ antiemetic action may be explained by the decrease in serotonin levels that it 
produces in area Postrema through its action on GABA receptors. 
4. In vitro model suggests that propofol has no direct effect on 5-HT3 receptors 
From these studies, though the exact location and mechanism of its antiemetic effect 
remains obscure, the probable site would be decrease in serotonin levels in area postrema. 
Dosage and blood levels 
Inclusion  of  Propofol  as  an  anaesthetic  agent  itself  offers  protection  against  post 
operative nausea and vomiting, since most anaesthetic agents are emetogenic unlike propofol. 
The blood levels needed to achieve loss of consciousness are 2.5 to 4.5 µg/ml and that 
required  for  surgery  are  2.5  to  8 µg/ml.  The  median  concentration  of  propofol  that  gives 
antiemetic effect is 343ng/ml with a range of 200ng/ml to 600ng/ml. (Gan et al)
a. As an induction agent 
The use of propofol at 2mg/kg for induction produces adequate blood levels to prevent 
vomiting, which are sustained for about 30 minutes. After 30 minutes, blood levels start falling 
and the  beneficial  antiemetic  effect  also  wanes  off.  So,  an  induction  dose  can  protect  the 
patients from vomiting, in a short duration surgery lasting for less than 30 minutes, for upto a 
period of 45-60 minutes.  However,  it  propofol is used as an induction agent in longer and 
major procedures, the incidence of nausea and vomiting are similar to other techniques.   
b. Maintenance agent 
Propofol,  when used as an maintenance agents,  achieves  more than necessary blood 
levels for its antiemetic effect and offers excellent protection from post operative nausea and 
vomiting for several hours. 
Since  the  blood  levels  necessary  to  maintain  anaesthesia  was  far  higher  than  for 
producing antiemetic effect, the concept of administering subhypnotic dose was introduced. 
c. Infusion of subhypnotic dose 
After  standard  induction  dose  of  2mg/kg   (or)  even  with  a  loading,  small  dose  of 
propofol,  10mg  to  20  mg,  and  then  starting  an  infusion  of  propofol  at  10µg/kg/minutes 
produces good antiemetic effect. The major advantage of such infusion is that this infusion can 
be continued in the post operative period for prolonged protection from post operative nausea 
and vomiting, without any major side effects and the patient will be more comfortable. This 
technique can be used even when the patient is undergoing surgery in regional anaesthesia. 
d. Single subhypnotic dose at end of surgery
Studies  have  shown  that  a  single  subhypnotic  dose  of  0.5mg/kg  or  10mg-20mg  is 
adequate to provide good antiemetic effect upto 4 hrs to 6 hrs post operatively. Even the emetic 
events  were  far  less  in  the  first  24  hours  period.  This  technique  has  been  tried  in 
mastoidectomy,  thyroidectomy,  and  specific  gynaecological  procedures  done  under  spinal 
anaesthesia. A single subhypnotic dose of 20mg intravenously at the end of surgery has been 
shown to be as good as 4mg of ondansetron or 10mg metoclopromide. 
e. “Sandwich technique” 
The use of propofol as an induction agent during general anaesthesia and a subsequent 
single dose of 20mg (or) 0.5 mg/kg, at the end of surgery is called the “sandwich technique”. It 
has been shown to be very effective in procedures lasting for 1-2 hours, with effective post 
operative relief of nausea and vomiting from 16-24 hours. The main advantage of this sandwich 
technique is its cost effectiveness in affording antiemesis upto a period of 24 hours. Studies 
have shown that this technique reduces the need for a rescue anti emetic in the post operative 
period.
REVIEW OF LITERATURE
1. Yoshitaka fuji et al., in archives of otolaryngology and head and neck surgery 2001, 
have  compared  propofol  as  an  antiemetic  agent  with  droperidol  and  metoclopromide  for 
middle ear surgeries and found Propofol to be a superior agent in preventing post operative 
nausea and vomiting. In their prospective randomized double blind study on ninety patients 
undergoing middle ear surgeries, they have administered Propofol 0.5 mg/kg or Droperidol 
20µg/kg  or  Metoclopromide  0.2mg/kg  intravenously  at  the  end  of  surgery.  They  have 
observed the patients from 0 hour to 3 hours for early events and from 3 rd hour to 24 hours 
post operatively for late events. The incidence of patients who were emesis free during the 0- 
to 3-hour period after receiving anesthesia was 93% for those who received Propofol, 73% for 
those  who  received Droperidol,  and  70%  for  those  who  received  Metoclopramide, 
respectively; the  respective  corresponding  incidence  during  the  3-  to  24-hour  period after 
receiving anesthesia was 90%, 67%, and 60%. 
They have concluded that a small dose of propofol is a better antiemetic than droperidol 
or metoclopramide for the prevention of postoperative nausea and vomiting after middle ear 
surgery. 
2. A Borgeal et al have published a paper on subhypnotic doses of propofol and its 
direct  antiemetic events.  They have used a  single small  subhypnotic  dose (10mg=1ml)  of 
propofol and have described large reduction of post operative nausea and vomiting from 81% 
in control group to 33% in propofol group. 
3.Mitsuko Numazaki MD et al – Canadian journal of anaesthesia 2005 Vol 52.    In their 
study on 80 thyroidectomy patients with a single small dose of propofol, (0.5mg/kg) it was 
proved that propofol has direct antiemetc effects. Further, 3 small single bolus doses were 
evaluated – 0.25mg/kg, 0.5mg/kg, 0.75mg/kg on thyroidectomy patients. In this study they 
have used a standard intravenous induction with Thiopentone, maintainance with  sevoflurane. 
At the end of surgery they have randomly administered a small sub hypnotic dose of Popofol 
intravenously. The subjects were divided into 3 groups and each group received Popofol in 
doses of – 0.25 mg/kg , 0.5 mg/kg, 0.75 mg/kg. The patients were observed for 24 hours in the 
post operative period for incidence of nausea and vomiting. The rate of emetic symptoms from 
0 to 24 hr after anesthesia was less in patients who had received propofol 0.5 mg·kg–1 (15%) or 
0.75 mg·kg–1 (15%) than in those who had received placebo (60%); (P < 0.05). However, there 
was no difference between propofol 0.25 mg·kg–1 (55%) and placebo. This study proves the 
efficiency of  subhypnotic doses of propofol in preventing post operative nausea and vomiting. 
4. Ramanathan et al  In Internet journal of anaesthesia ,2003 .    have used a small 
single bolus dose of propofol 20mg IV and have compared with a control group of 2ml normal 
saline IV, and have shown that there was  reduction in incidence of post operative nausea and 
vomiting when 20mg propofol was administered at  the end of surgery. Their study group 
consisted of 40 female patients undergoing vaginal hysterectomy under subarachanoid block. 
The antiemetic effect in their study lasted from 4 hours to 24 hours. The incidence of post 
operative nausea and vomiting in the study group was 25% only while the incidence was 65 % 
in the control group.
This study proves the efficiency of a small dose of propofol – 20 mg intravenous for 
regional  anaesthesia  procedures  in  preventing  nausea and vomiting  in  the  post  operative 
period.
5.  Bouley  and  Craig  R,  -  in  their  article  in  current  opinion  in  Anaesthesiology, 
December 2001,  have described high incidence of  post  operative  nausea and vomiting in 
otolarygological procedures and that inclusions injection propofol in the anaesthetic technique 
reduced the incidence as much as 40%. 
6. Soppitt AJ, Glass PS, Howell S, Gan TJ have surveyed the use of propofol for its 
antiemetic effects in United States. 
In their survey they found that in a group of 150 anaesthesiologist, 84% used 
propofol as an anaesthetic agent because it had antiemetic properties. 63% reported that a 
single  induction  dose  of  propofol  for  surgeries  less  than 1 hour prevented  post  operative 
nausea and vomiting.
7. Tong J. Gan et al – Deparment of Anaesthesia , duke medical center U.S.A,   have 
given elaborate guidelines regarding investigation and evaluation of agents that prevent post 
operative nausea and vomiting. In their study they have enumerated the risk factors for post 
operative  nausea  and  vomiting  and  have  outlined  the  measures  to  prevent  it.  They  have 
reported propofol as an antiemetic under guideline IA. 
8. Apfel et al – in their classic study with 2722 patients developed a simplified risk 
score consisting of four predictors. 1) female gender,              2) previous history of motion 
sickness (or) post operative nausea and vomiting, 3) non smoking status, 4) use of opiods. The 
risk indices were 10%, 21%, 39%, 61%, 79% respectively.
9. Cliff A. Megerian et al – Archieve of otolaryngology , Head and Neck surgery 
2000,  have  studied  the  effects  of  post  operative  nausea  and  vomiting  in  outpatient 
tympanomastoid procedures. They have reported that it is the major reason for readmission 
after 23 hrs and the cause for prolonged stay in hospital. 
10. P. Ewalenko, S Janny, G. Andry – In British journal of Anaesthesia, 1996 , Vol. 
77 . They  have studied the effect of a 20 hour post operative infusion of propofol 0.1mg/kg/hr 
and compared with control during their 20 hour study period. There was no incidence of post 
operative nausea and vomiting in the study group.      
MATERIALS AND METHODS
This  is  a  prospective  double  blind  study  conducted  at  Government  Rajaji  Hospital 
attached to Madurai Medical College. 
After approval by ethical committee, 90 patients of ASA grade I of age group 10-20 
years, coming for Modified radical Mastoidectomy were enrolled in the study. 
Patients  with  history  of  allergy  to  egg  proteins,  inadequate  starvation,  history  of 
smoking, history of motion sickness were excluded from the study. 
Patients  were  randomly  allocated  into  one  of  the  three  study  groups,  each  group 
consisting of thirty patients (n = 30).
 Patients were premedicated with injection  Pentazocine 0.6mg/kg and Atropine 0.02mg/
kg intramuscularly 45 minutes prior to induction of anaesthesia. 
On  arrival  to  the  operation  theatre,  intravenous  access  was  established.  Injection 
ranitidine 50mg was given intravenously. Ringers lactate infusion started. 
Pulse oximeter and non invasive blood pressure monitor was attached and pre induction 
values were recorded. 
Fluid infusion rates  were calculated from 4:2:1 rule  and adequate fluid balance was 
taken care.   
According to the randomly allocated group patients received: 
Group A (n=30)
 Injection Thiopentone 5mg/kg intravenously for induction.
Normal saline 2 ml at the end of surgery 
Group B  (n=30)
Injection propofol 2mg/kg intravenously. 
Normal saline 2 ml at the end of surgery
Group C (n=30)
Injection Propofol 2 mg/kg intravenously 
Injection Propofol 0.5 mg/kg  made upto 2ml at the end of surgery
All the 90 patients were maintained with 66% Nitrous oxide and 33% oxygen, injection 
Atracurium in titrated doses for immobility and facilitating controlled ventilation. 
Injection pentazocine was used as analgesic. 
After  positioning,  surgery  proceeded.  Pulse,  blood  pressure,  oxygen saturation  were 
monitored continuously. 
Duration of the surgery was recorded. At the end of surgery, patient ventilated with 
100%  oxygen  for  10  minutes  and  residual  neuromuscular  blockade  was  antagonised  with 
Neostigmine 0.04mg/kg and Atropine 0.02mg/kg intravenously. 
If the patient belonged to study Group C, patient received 0.5mg/kg of propofol at the 
end of surgery, when the last sutures were being applied.
when propofol was administered as induction agent it was mixed with 1ml of 2% preservative 
free Lignocaine. 
All the patients were extubated inside the operation theatre and observed for 10 minutes 
before shifting to recovery room.
Patients were observed for 4 hours in recovery room  and for 24 hours in post operative 
ward.
The nausea and vomiting were graded as follows: 
Emesis score 
 0 - no nausea 
1 - mild nausea 
2 - severe nausea 
3 - retching 
4 - one episode of vomiting 
5 - vomiting greater than one episode
Parameters observed during intraoperative period were- pulse rate, blood pressure and 
oxygen saturation. 
The post operative analgesia was injection diclofenac – 25 to 50mg intra muscular. 
All the emetic events were recorded on hourly basis.
0-1 
hours
1-2 
hours
2-3 
hours
3-4 
hours
4-24 
hours
Rescue anti 
emetic
The patient was assessed at the end of the each hour and data was collected about the 
emetic events that occurred during that hour. 
If vomiting occurred more than twice in that hour, the score was recorded as 5, and 
rescue anti emetic, injection .Metoclopromide 10 mg was given intravenously. The time for 
first antiemetic administration was noted.
All the events were recorded in the data entry charts and noseworthy anaesthesia record charts.
The study ends at 24 hours from the time of extubation.
The results were analysed with epiinfo software for statistics for epidemiology develop 
by World health organization     

RESULTS AND ANALYSIS
The data that were collected and analysed in this study were emetic events graded on a 5 
point scale system
0 – no nausea
1- mild nausea
2- severe nausea
3- retching
4- vomiting 1 episode
5- vomiting > 1 episode
Periods of observation were from 0 to 1 hour, 1 to 2 hours, 2to 3 hours, 3 to 4 hours and 
from 4 to 24 hours.
During statistical analysis  Scores 0 and 1 (no nausea or mild nausea) were considered 
FAVOURABLE EVENTS, and scores 3, 4, 5 – (severe nausea, retching, vomiting 1 time or 
vomiting > 1 time) were considered UNFAVOURABLE EVENTS.
Statistical analysis was done for each time period in each of the study group to ascertain 
the incidence of emetic events in that group and compared it with other groups.
The statistical significance was determined with KrausKall Wallis CHI SQUARE TEST. 
A    P value < 0.05 was considered significant
The age and sex comparison were as follows
Table 1. age distribution
Age 
group
Group A Group B Group C
Number Percent Number Percent Number Percent
10 – 15 6 20 % 11 36.7 % 10 33.3 %
15-   20 24 80 % 19 63.3 % 20 66.7%
Total 30 100% 30 100% 30 100%
Mean 17.2 16.2 16.2
S.D. 2.7 3.2 3.5
From the table it is evident that age distribution is comparable in the three groups and 
distribution of patients in the age group 15 to 20 years is more.
Table 2: sex distribution
Sex Group A Group B Group C
Male 24 80 % 15 50 % 11 36.7 %
Female 6 20 % 15 50 % 19 63.3 %
Group A consists of more male patients 
Group B consists of equal gender distribution 
Group C Consists of more female patients 
Analysis of the immediate recovery period: 0 hour to 1 hour:
Event Group A  Group B Group C
points↓ Score Percent Score Percent Score Percent
0 9 30 % 6 20  % 11 36.7 %
1 1 3.3 % 13 43 % 9 30 %
2 0 0 % 6 20 % 4 13.3 %
3 7 23.3 % 4 13.3 % 3 10 %
4 10 33.3 % 1 3.3 % 3 10 %
5 3 10 % 0 0 % 0 0 %
Analysis: 
Group A – Favourable event points – 10 
                Unfavourable events points – 20
Group B – Favourable event points- 19 
                   Unfavourable event points – 11
Group C – Favourable event points – 20 
               Unfavourable  event points – 10
Statistical significance:
P value between Group A and Group B - 0.0388  (significant)
P value between Group A and Group C -  0.0201  (significant)
P value between Group B and Group C -  0.9999 (not significant)
Thus in the analysis we can see that in both group B and Group C the incidence of 
emetic events are very low and similar , where as the incidence is high in group  A.  
Analysis of early events : 1 hour to 2 hours
event Group A Group B Group C
Points↓ Score Percent Score Percent Score Percent
0 1 3.3 % 9 30  % 14 40.7 %
1 5 16.7 % 13 43 % 7 23.3 %
2 6 20 % 6 20 % 5 16.7 %
3 7 23.3 % 2 6.1 % 2 6.7 %
4 3 10 % 0 0 % 2 6.7 %
5 8 26.7 % 0 0 % 0 0 %
Analysis: 
Group A – Favourable event points – 6
                Unfavourable event points – 24
Group B – Favourable event points- 22
          Unfavourable event points – 8
Group C – Favourable event points – 21 
               Unfavourable  event points – 9
Statistical significance:
P value between Group A and Group B - 0.0001  (significant)
P value between Group A and Group C - 0.0002  (significant)
P value between Group B and Group C -  0.9999 (not significant)
In the second hour analysis we can see that the emetic events are high in group A and 
comparably lower in the groups B and C
Analysis of 2  nd   to 3 rd    post operative hours 
Event Group A Group B Group C
Points↓ Score Percent Score Percent Score Percent 
0 5 16.7% 7 23.3  % 13 43.3 %
1 6 20 % 4 13.3 % 7 23.3 %
2 5 16.7 % 7 23.3 % 3 10 %
3 2 6.7 % 5 16.7 % 3 10 %
4 5 16.7 % 2 6.7 % 3 10 %
5 7 23.3 % 5 16.7 % 1 3.3 %
Analysis: 
Group A – Favourable event points – 11
                Unfavourable events points – 19
Group B – Favourable event points- 11
                   Unfavourable event points – 19
Group C – Favourable event points – 20 
               Unfavourable  event points – 10
Statistical significance:
P value between Group A and Group B -  0.7888 (not significant)
P value between Group A and Group C -  0.0388 (significant)
P value between Group B and Group C -  0.0388 (significant)
The emetic events are almost similar in Group A and Group B at the 2nd to 3rd hour. The 
incidence of nausea and vomiting is still lower in Group C when compared to Group A and B
Analysis of 3  rd   to 4 th   hour 
event Group A Group B Group C
Points↓ Score Percent Score Percent Score Percent
0 6 20 % 5 16.7  % 15 50 %
1 5 16.7 % 5 16.7 % 5 16.7 %
2 4 13.3 % 8 26.7 % 2 6.7 %
3 6 20 % 4 13.3  % 6 20.0 %
4 2 6.7 % 2 6.6  % 2 6.7 %
5 7 23.3 % 6 20.0 % 0 0 %
Analysis: 
Group A – Favourable event points – 11
                Unfavourable events points – 19
Group B – Favourable event points- 10
                   Unfavourable event points – 20
Group C – Favourable event points – 20 
               Unfavourable  event points – 10
Statistical significance:
P value between Group A and Group B - 0.7884 (not significant)
P value between Group A and Group C - 0.0387  ( significant)
P value between Group B and Group C - 0.0201  ( significant)
The patients in group C still have a distinct advantage of low incidence of emetic events 
than that of Group A and B. The emetic events in group B is similar to that of Group A.
Analysis of 4  th   hour to 24 th   hour – late events 
Event Group A Group B Group C
Points↓ Score Percent Score Percent Score Percent
0 7 23.3 % 7 23.3  % 12 40 %
1 6 20 % 5 16.7 % 5 16.7 %
2 4 13.3 % 7 23.3 % 3 10 %
3 5 16.7 % 2 6.7 % 3 10 %
4 4 13.3 % 2 6.7 % 0 0 %
5 4 13.3 % 7 23.3 % 7 23.3 %
Analysis: 
Group A – Favourable event points – 13
                Unfavourable events points – 17
Group B – Favourable event points- 12
                   Unfavourable event points – 18
Group c – Favourable event points – 17
               Unfavourable  event points – 13
Statistical significance:
P value between Group A and Group B - 0.9999 (not significant)
P value between Group A and Group C - 0.4386  (not significant)
P value between Group B and Group C - 0.3014  (not significant)
The analysis of late postoperative emetic events implicate that group c patients have low 
incidence of nausea and vomiting while the difference is not seen in group A and B
SEVERITY OF POST OPERATIVE NAUSEA AND VOMITING: QUANTIFICATION 
OF EMETIC EVENTS
GROUP A GROUP B GROUP C
RANGE 0-22 0 – 15 0 – 20
MEAN 12.77 8.94 6.83
S.D. 4.95 4.38 5.45
The above table quantifies the range of event point that were scored by the patients in 
the study. 
RANGE: The lowest score that was obtained by a patient in any of the group was 0 – no 
nausea and vomiting throughout the 24 hour period. The highest score was recorded in the 
group A is 22, 15 in group B and 20 in Group C.
MEAN: The average emetic event score obtained by patient belonging to Group A is 
12.77 which is higher than Group B- 8.94  and Group C - 5.45. The value of mean is lowest in 
group C suggesting that the average scores obtained by patients if group C is lower than group 
A and B .  
RESCUE ANTI EMETIC REQUIREMENT
GROUP A GROUP B GROUP C
Number Percent Number Percent Number Percent
GIVEN 22 73.3 17 56.7 10 33.3
NOT GIVEN 8 26.7 13 43.3 20 66.7
Statistical significance:
P value between Group A and Group B - 0.2789  (not significant)
P value between Group A and Group C - 0.0044  (significant)
P value between Group B and Group C - 0.1194  (not significant)
On analyzing the statistical significance in rescue anti emetic administration, we can see 
that group A had highest requirement of rescue antiemetics which is not very higher than that 
from Group B. but requirement in Group C is very low and comparable with that in Group A
GROUP A GROUP B GROUP C
RANGE 45 – 260 150 - 290 150 - 460
MEAN 133.9 220.6 335.0
S.D. 68.7 42.3 125.9
From this  we  can  see  that  group A patients  required  rescue  antiemetic  earlier  (133 
minutes) than group B and C. group C patients required rescue antiemetic only after an average 
of 335 minutes
Mean arterial pressure
GROUP A GROUP B GROUP C
RANGE 88-110 82 -108 80-106
MEAN 95.6 90.3 91.3
S.D. 4.6 18 5.8
Mean arterial pressure is comparable in all the 3 groups 
DISCUSSION
Post operative nausea and vomiting is a major post operative problem in mastoidectomy 
surgeries. It is due to various factors like middle ear handling, use of nitrous oxide and opioids. 
In centres where Tympanomastoid surgeries are done as out patient procedures, post operative 
nausea and vomiting is  the major cause for readmission.  There are many prophylactic  and 
treatment  modalities  to  prevent  and  treat  post  operative  nausea  and  vomiting.  Of  special 
interest is use of Propofol. Propofol is an intravenous induction agent that has two distinct and 
clear cut advantages - one is its quick recovery and other is its antiemetic effect when used in 
day care surgeries
Use of propofol as maintenance agent has clear advantages in preventing post operative 
nausea and vomiting. But this regime is costly. Use of subhypnotic dose in addition to using 
propofol for induction dose has been described as sandwich technique and has been shown to 
prevent post operative nausea and vomiting for upto 24 hours post operatively.
In our study,  the control  group,  Group A consisted of mastoidectomy under general 
anaesthesia  with  thiopentone  induction,  nitrous  oxide,  oxygen,  opioid,  (Pentazocine) 
maintenance. In this group, Nausea and vomiting in the first 4 hours and subsequent 20 hours 
was distressing to the patients. Nearly 65% (20 out or 30) had severe vomiting that required an 
rescue antiemetic therapy, early in the post operative period. This group also had persistent 
vomiting that required a second dose of antiemetic agent.
In their study, Cliff A. Megerian has described the same fact that in         out -patient 
tympanomastoid surgeries, only one third patients could be safely discharged on the same day. 
75% patients had pain or post operative nausea and vomiting as the factor that prevented their 
discharge, out of which post operative nausea and vomiting contributed to the 65%. The main 
reason  being  pain  could  be  tackled  early  and  effectively  NSAID therapy,  but  nausea  and 
vomiting could not be treated with the same precision using a single drug regime.
Bailey  Craig  R,  in  the  journal  current  opinion  in  anaesthesiology  have  described 
propofol  as  intravenous  induction  agent  that  could  provide  clear  headed  recovery,  less 
incidence of nausea and vomiting, and earlier hour discharge in outpatients procedures with 
lesser use of antiemetic agents. When studying mastoidectomy surgeries, even though propofol 
protected the patient during early recovery period upto 3 hours, and patients were discharged 
early, readmission to hospital before 23 hours was still high due to post operative nausea and 
vomiting.  The main reason was induction dose did protect  the  patient  from post  operative 
nausea and vomiting to be discharged early, but vomiting  occured in the late post operative 
period necessitating a readmission.
This is true in the study group B. The patients were induced with propofol and normal 
saline 2ml was given at end of surgery. Though the incidence of nausea and vomiting in the 
first 2 hour post operative period was significantly low ( 36.7%,26.7%), the incidence was still 
higher in the remaining 22 hours. The only difference was, the rescue antiemetic requirement 
was (56% in group B and 75% in group A) less and the need for a second dose of rescue 
antiemetic was  low.
In  our  study group C,  propofol  in  a  does  of  2mg /  kg was  used  to  induce general 
anaesthesia. Anaesthesia was maintained with opioid ,   nitrous oxide and oxygen. At end of 
surgery, propofol 0.5mg /kg was administered. After adequate recovery from neuromuscular 
blockers, patient was extubated. The incidence of Nausea and vomiting was very low (43%) in 
the immediate recovery for the first 4 hours. During the 4-24 hour period, though the incidence 
of  nausea was the  same,  events  of  retching and vomiting  were  very low.  The duration of 
administration of  the  first  antiemetic  in  also significantly  longer  (335 Minutes  in  group C 
compared with 130 minutes in group A and 220 minutes in group B) . Moreover, second dose 
of antic emetic was rarely needed in this group. 
Yoshitaka et al have done a comparative study with 0.5 mg/kg  of propofol administered 
at the end of surgery the incidence of emesis free period in the first 3 hours postoperatively was 
93% and in the 3-24 hour period was as low as 90%. There were no clinically adverse events in 
any of the study groups.
Propofol at such small doses lack sedative, dysphoric and extrapyramidal effects 
SUMMARY AND CONCLUSION
Mastoidectomy done under general anaesthesia predisposes the patient to nausea and 
vomiting in the postoperative period 
Use of propofol as an induction agent in mastoidectomy surgery protects the patient 
from nausea and vomiting in the early post operative period (0-4 hours). The antiemetic effect 
in more pronounced in the first and second post operative hour. But after 4 hours, the incidence 
of nausea and vomiting reaches the same value of any technique which does not use propofol.
Use of  propofol  for  induction and then administering a subhypnotic dose  (sandwich 
technique) at end of surgery afford protection from nausea and vomiting for upto 24 hours. The 
incidence  of  nausea  and  vomiting  in  the  early  post  operative  period  is  lower  than  using 
propofol for induction alone, and significantly lower in the remaining 4-24 hours as reflected 
by  lower  incidence  of  rescue  antiemetic  requirement  and  longer  time  intervals  for 
administration of first antiemetic dose.
Combination of induction dose of propofol and subhypnotic dose of propofol at the end 
of surgery  prevents nausea and vomiting in both early and late post operative period.     
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PROFORMA AND OBSEVATON SHEET
STUDY GROUP: DATE:
 
         A THIOPENTONE(I)
         B PROPOFOL(I)
         C PRO(I)+ PRO(SH)
 
NAME: AGE: SEX: IP.NO.
SYSTEMIC DISEASES:
PREVIOUS SURGERIES/ANAESTHESIA:
ALLERGY/DRUG INTAKE:
VITALS:  WEIGHT: PULSE: BLOOD PRESSURE: R.R.
GENERAL  :  ANEMIA: CYANOSIS: EDEMA:
SYSTEMIC:
CVS: RS: P/A: CNS:
STARVATION:                     HYDRATION: 
ASA RISK:
AIRWAY ASSESSMENT:
PREMEDICATION:
INDUCTION: 
INTUBATION:
MAINTAINANCE:
FLUIDS:
MONITOIRING:
DURATION OF SURGERY:
REVERSAL:
INTRAOP EVENTS IF ANY:
RECOVERY TIME:
TIME
PULSE
BP
SPO2
MODIFIED ALDERETE RECOVERY SCORE: AFTER 
EXTUBATION
ACTIVITY
RESPIRATION
CIRCULATION
CONCIOUSNESS
OXYGEN 
SATURATION
ACTIVITY:    2- MOVES ALL 4 LIMBS,    1- MOVES 2 LIMBS,    0- UNABLE TO MOVE
RESPIRATION:  2- BREATHES DEEP& COUGHES, 1-DYSPNEIC & SHALLOW, 0-APNEIC
CIRCULATION: 2- BP=BASELINE BP+20, 1- BP= BL BP+ 20-50, 0- BP=>BL  BP+50
CONCIOUSNESS: 2- FULLY AWAKE, 1- AROUSABLE, 0- NO RESPONSE
O2 SATURATION: 2- SPO2> 92%, 1- SPO2 >92% WITH O2 , 0- SPO2<90% WITH O2
PONV score:
0 = No nausea/vomiting
1 = Mild Nausea 
2 = Severe Nausea
3= Retching
4=One episode of vomiting
5= Vomiting greater than 1 episode
0-1 HOURS 1-2hrs 2-3 hrs 3-4 hrs 4-24 hrs
  
EARLY EVENTS:  LATE EVENTS:
 
Minimum score: 0
Maximum score: 25
Observed score: ____
TIME INTERVAL BETWEEN EXTUBATION AND FIRST DOSE ANTI 
EMETIC:_____
RESCUE ANTIEMETIC-
INJ METOCLOPROMIDE 10 MG IV IF PONV SCORE EXCEEDS 5- (YES/NO)
PHARMACOLOGIST VIEW OF EMETIC 
STIMULI
Periphery 
     
(5HT3, D2, M)     
STOMACH 
SMALL 
INTESTINE (5HT
3
)
Memory, Fear, Dread, 
anticipation
HIGHER CENTRESensory Input
(Pain, Smell, Sight)
EMETIC CENTRE
Medulla
SOLITARY TRACT 
NUCLEUS 
(5HT3, D2, M1, H1)
AREA POSTREMA
CTZCEREBELLUM
Vagal and 
sympathetic 
afferents
Pharnyx
(gagging) 
LOCAL IRRITANTS
Cytotoxic drugs
CuSo4
Radiation
Bacteria
Viruses
BLOOD BORNE EMETICS
Cytotoxic drugs
Opiods
Cholinomimetics
Digoxin
L-dopa, emetine
Bromocriptine
